TGF-β1 Gene Polymorphisms and Peritoneal Equilibration Test Results in CAPD Patients

REFERENCES

• Ha H, Lee HB. Effects of high glucose on peritoneal mesothelial cell biology. Perit Dial Int. 2000; 20: 15–18
   Google Scholar
• Hung KY, Chen CT, Huang JW, Lee PH, Tsai TJ, Hsieh BS. Dipyridamole inhibits TGF-β-induced collagen gene expression in human peritoneal mesothelial cells. Kidney Int. 2001; 60: 1249–1257
   Google Scholar
• Ates K, Koç R, Nergizoglu G, Ertürk S, Keven K, Sen A, Karatan O. The longitudinal effect of a single peritonitis episode on peritoneal membrane transport in CAPD patients. Perit Dial Int. Mar–Apr, 2000; 20(2)220–226
   Google Scholar
• Kang DH, Hong YS, Lim HJ, Choi JH, Han DS, Yoon KI. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-b1 of human peritoneal mesothelial cells: Effects of cytokine costimulation. Perit Dial Int. 1999; 19(3)221–230
   PubMed Web of Science ®Google Scholar
• Holmes CJ, Shockley TR. Strategies to reduce glucose exposure in peritoneal dialysis patients. Perit Dial Int. 2000; 20(Suppl. 2)37–41
   Google Scholar
• Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA. Mar 28, 2000; 97(7)3479–3484
   Google Scholar
• Lin CY, Chen WP, Fu LW, Yang LP, Huang TP. Persistent transforming growth factor beta-1 expression may predict peritoneal fibrosis in CAPD patients with frequent peritonitis occurrence. Adv Perit Dial. 1997; 13: 64–71
   PubMedGoogle Scholar
• Li B, Khanna A, Sharma V, Singh T, Suthanthiran M, August P. TGF-β1 DNA polymorphisms, protein levels, and blood pressure. Hypertension. 1999; 33: 271–275
   PubMed Web of Science ®Google Scholar
• Twardowski ZJ, Nolph KD, Khanna R, Prowant BF, Ryan LP, Moore HL, et al. Peritoneal equilibration test. Perit Dial Bull. 1987; 7: 138–147
   Web of Science ®Google Scholar
• Naiki Y, Maeda Y, Matsuo K, Yonekawa S, Sakaguchi M, Iwamoto I, Hasegawa H, Kanamaru A. Involvement of TGF-beta signal for peritoneal sclerosing in continuous ambulatory peritoneal dialysis. J Nephrol. Jan–Feb, 2003; 16(1)95–102
   Google Scholar
• Medcalf JF, Walls J, Pawluczyk IZA, Harris KPG. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): The role of TGF-β1. Nephrol Dial Transplant. 2001; 16: 1885–1892
   Google Scholar
• Linden GJ, Haworth SE, Maxwell AP, Poulton KV, Kyer PA, Middleton D, Irwin CR, Marley JJ, McNamee P, Short CD, Hull PS, James JA. The influence of transforming growth factor-b1 gene polymorphisms on the severity of gingival overgrowth associated with concomittant use of cyclosporin A and a calcium channel blocker. J Periodontol. 2001; 72: 808–814
   Google Scholar
• El-Gamel A, Awad MR, Hasleton PS, Yonan NA, Hutchinson JA, Campbell CS, Rahman AH, Deiraniya AK, Sinnott PF, Hutchinson IV. Transforming growth factor-beta (TGF-β1) genotype and lung allograft fibrosis. J Heart Lung Transplant. 1999; 18: 517–523
   PubMed Web of Science ®Google Scholar
• Medcalf JF, Walls J, Pawluczyk IZA, Harris KPG. Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (HPMC): The role of TGF-β1. Nephrol Dial Transplant. 2001; 16: 1885–1892
   Google Scholar
• Wang T, Chen YG, Ye RG, Li SL, Li HQ, Chen YX. Effect of glucose on TGF-β1 expression in peritoneal mesothelial cell. Advances in Peritoneal Dialysis, R Khanna. Peritoneal Dialysis Publications. 1995; 7–10,
   Google Scholar
• Kumano K, Schiller-Moran B, Hjelle JT, Moran JE. Effects of high glucose levels on cell proliferation and TGF-13 expression in cultured rat mesothelial cell. J Am Soc Nephrol. 1993; 4: 410
   Google Scholar
• Jörres A, Bender TO, Witowski J. Glucose degradation products and the peritoneal mesothelium. Perit Dial Int. 2000; 20(Suppl. 5)19–22
   Google Scholar
• Honda K, Nitta K, Horita S, Yumura W, Nihei H, Nagai R, Ikeda K, Horiuchi S. Accumulation of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration. Nephrol Dial Transplant. 1999; 14: 1541–1549
   PubMed Web of Science ®Google Scholar
• Gotloib L, Wajsbrot V, Shostak A, Kushnier R. Experimental approach to peritoneal morphology. Perit Dial Int. 1994; 14(Suppl. 3)S6–S11
   Google Scholar
• Dobbie JW, Anderson JD, Hind C. Long-term effects of peritoneal dialysis on peritoneal morphology. Perit Dial Int. 1993; 13(Suppl. 2)S23–S26
   Google Scholar
• Gotloib L, Wajsbort V, Shostak A, Kushneier R. Morphology of the peritoneum: effect of peritoneal dialysis. Perit Dial Int. 1995; 15(Suppl. 7)S9–S12
   Google Scholar
• Dobbie JW. Durability of the peritoneal membrane. Perit Dial Int. 1995; 15(Suppl. 7)S87–S92
   Google Scholar
• Margetts PJ, Kolb M, Galt T, Hoff CM, Shockley TR, Gauldie J. Gene transfer of transforming growth factor-β1 to the rat peritoneum: Effects on membrane function. J Am Soc Nephrol. 2001; 12: 2029–2039
   PubMed Web of Science ®Google Scholar
• Holweg CT, Baan CC, Balk AH, Niesters HG, Maat AP, Mulder PM, Weimar W. The transforming growth factor-beta1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation. Transplantation. May 27, 2001; 71(10)1463–1467
   Google Scholar
• Awad MR, El-Gamel A, Hasleton P, Turner DM, Sinnott PJ, Hutchhinson IV. Genotypic variation in the transforming growth factor-β1 gene. Transplantation. 1998; 66: 1014–1020
   PubMed Web of Science ®Google Scholar